Foundation / Corporation
Lymphoma Research Foundation
09/06/17 5:00 PM EST
Grants of up to $50,000 per year to USA and Canada nonprofit organizations, universities, colleges, laboratories, and hospitals for correlative translational or clinical studies that address lymphomas in adolescents and young adults. Studies may address either the biomarkers and biology of adolescent/young adult (AYA) lymphomas, or the clinical outcomes/survivorship, and health services studies that specifically impact the AYA lymphoma population.
Innovative research by definition may uncover new questions and new areas requiring investigation. Basic funding often does not allow for additional, correlative studies to explore these areas. Adolescent/young adult patients with lymphoma are an understudied population that would particularly benefit from adjunct studies. The intention of the current request for proposals is to fund adjunct studies to complement and synergize with ongoing lymphoma clinical trials, as well as facilitate cooperation between pediatric and adult oncologists who work with this population. The applications should clearly focus on lymphoma research and have a high degree of relevance to research questions pertinent to adolescent and young adult lymphomas. Projects that incorporate cooperation between pediatric oncology researchers or institutions and adult oncology researchers or institutions are strongly encouraged. Projects should be based at academic or nonprofit research institutions in the United States or Canada.
Research Objectives and Evaluative Factors:
Applicants are encouraged to design proposals that will complement existing, ongoing clinical trials/recently completed; including studies where data collection will be completed in the time frame of the grant. Possible projects include correlative studies to ongoing trials (including translational laboratory or imaging studies), utilization of patient samples for specialized analyses, quality of life and survivorship issues, and Phase I or II clinical trials of novel therapeutic approaches.
Applications will be reviewed by the LRF Scientific Advisory Board who will make recommendations on applications to the LRF Board of Directors. The LRF Board of Directors will make final funding decisions based on available funds and program priorities. Reviewers will be asked to evaluate the application in order to judge the likelihood that the proposed research will have a substantial impact on the pursuit of this goal:
1. Applicant qualifications and research experience;
2. Innovation of proposed research strategy and objectives;
3. Quality and impact of previous work in AYA lymphomas and lymphoma in general;
4. Potential translational/clinical application to advancing treatment and/or improving outcomes for AYA lymphoma patients;
5. Reviewers’ estimation of likely success and impact of the project;
6. Responsiveness of application to the priority research areas listed above, including collaborative
7. Resources, such as facilities and patient study group, available to support the project;
8. Financial resources available from other sources and overlap with possible LRF funding.
The application does not need to be strong in all categories to be judged as likely to have major scientific impact and thus be worthy of a high ranking. Ranking will be assigned based on the overall merit of the proposal. However, please note that applications that do not directly address AYA lymphomas will be disqualified.
Additional review considerations:
-Focused on the diagnosis, treatment, outcomes, and/or any of the below priority areas as they affect adolescent and young adult patient populations. Projects may focus on either biomarker/biology/imaging priority areas, or clinical outcomes/survivorship/health services priority areas.
-Associated with an ongoing, clinical research project focused specifically on lymphoma and/or any of its subtypes.
-Intended to test a new hypothesis based on preliminary findings in the major study.
-Capable of furthering the understanding of lymphoma and/or its diagnosis and treatment.
-Have direct clinical relevance/involvement or include primary lymphoma patient samples or
data. Research proposals should specify the number of AYA patients or samples in the study.
-Collaboration between pediatric oncology researchers or institutions and adult oncology
researcher or institution is strongly encouraged.
Priority areas identified for funding are:
Biomarker/Biology of AYA Lymphomas:
-Genomic/genetic analysis of lymphoma. What are the critical pathways involved in AYA lymphomagenesis and what are the molecular predictors of tumor behavior?
-Identification of biomarkers or biologic features. What biologic features and/or biomarkers of lymphoma are predictive of the outcome of AYA lymphomas?
-Host-Tumor Interactions. How does the immune system modulate lymphoma? Does the tumor microenvironment influence resistance to therapies?
-Heterogeneity of lymphoma behavior. What are the molecular, biologic, immunologic and micro-environmental factors determining the variability in clinical behavior of AYA lymphomas? In what ways do lymphomas in the AYA population differ from those occurring in pediatric or older adult groups?
-Drug resistance. What are the molecular, biologic, immunologic and micro-environmental factors determining resistance to key anti-lymphoma agents?
-Novel therapies. Projects focused on new therapeutics should explore and elucidate the mechanisms of action.
-Imaging. What are common imaging characteristics of AYA lymphomas? What imaging modalities offer an accurate method for staging AYA lymphomas?
Clinical Outcomes/Health Services:
-Enhancement of accrual of patients to clinical trials. Despite a plethora of attractive agents for clinical trials, progress is slow due to the low accrual rate of patients to clinical trials in the USA. Convincing strategies with measurable endpoints documenting improvement in lymphoma trial accrual will be considered for funding.
-Quality of Life. What factors impact the quality of life of AYA lymphoma patients?
-Outcomes in AYA lymphoma. To better understand socioeconomic (race, ethnicity, insurance status, economic status) and psychosocial factors (community vs. academic treatment center, pediatric vs. adult providers, etc.) that impact outcomes in AYA lymphomas.
-Late Effects and Second Cancers. What are the late effects and second cancers associated with
modern AYA lymphoma therapy? What are the risk factors (both host, treatment-related, and genetic) that impact the incidence or severity of late effects and second cancers in modern AYA lymphoma therapy?
-Long-Term Follow Up/Survivorship Care. To describe transition practices for AYA lymphoma patients from active treatment to long-term follow up. To understand the compliance of AYA lymphoma survivors with adhering to long-term follow-up guidelines.
GrantWatch ID#: 144185
Up to three projects will be funded based on the recommendations of the grant review meeting and funding availability. The Foundation hopes to fund at least one project in both biomarkers/biology and clinical outcomes/survivorship/health services.
Applications may be for a budget of no more than $50,000 per year ($100K in total over 2 years).
Applications may be for a time frame of up to 2 years in duration. Funding will commence at the earliest on March 1, 2018.
Before starting your grant application, please review the funding source's website listed below for updates/changes/addendums/conferences/LOIs.
All interested applicants must submit their applications online through proposalCENTRAL:
Whitney Steen, Manager, Research Grants and Communications
USA: Alabama; Alaska; Arizona; Arkansas; California; Colorado; Connecticut; Delaware; Florida; Georgia; Hawaii; Idaho; Illinois; Indiana; Iowa; Kansas; Kentucky; Louisiana; Maine; Maryland; Massachusetts; Michigan; Minnesota; Mississippi; Missouri; Montana; Nebraska; Nevada; New Hampshire; New Jersey; New Mexico; New York City; New York; North Carolina; North Dakota; Ohio; Oklahoma; Oregon; Pennsylvania; Rhode Island; South Carolina; South Dakota; Tennessee; Texas; Utah; Vermont; Virginia; Washington, DC; Washington; West Virginia; Wisconsin; Wyoming
Canada: Alberta; British Columbia; Manitoba; New Brunswick; Newfoundland and Labrador; Northwest Territories; Nova Scotia; Nunavut; Ontario; Prince Edward Island; Quebec; Saskatchewan; Yukon;
Grants to USA government agencies, educational institutions, nonprofit organizations, faith-based and community organizations, and tribal governments for activities to reduce violent crime in local neighborhoods. Interested applicants are advised that required registra
Fundraising opportunity for USA, Canada, and International nonprofit organizations to host a jazz concert held in honor of their organization or cause. Applicants must contact the funding source prior to applying. In addition to funds raised through concert ticket sales
Grants to USA nonprofit organizations to reduce social inequality and promote solutions to the climate crisis. Eligible programs will address the areas of racial and economic justice, corporate and political accountability; voice, creativity, and culture; and an inclusi
Grants to USA nonprofit organizations and Tribes to provide technical assistance and counseling for disadvantaged small businesses. Applicants are advised that required registrations may take several weeks to complete. The purpose of the available funding is to support
Grants of up to $5,000 and grants of up to $20,000 to Virginia nonprofit organizations for programs that promote the humanities in local communities. Certain applicants are required to submit an LOI prior to a full grant application. All applicants are advised to contac
Grants to USA nonprofit organizations and eligible agencies to increase organizational capacity to improve housing practices. Applicants are advised that required registrations may take several weeks to complete. Funding is intended to strengthen organizational capacity
Grants to USA and Canada nonprofit charitable organizations to impact public policy in a variety of national and international issues. In previous years, grants have been awarded for general operations and project support to think tanks, national councils, judicial orga
Grants to New York and Pennsylvania families living in eligible areas and caring for a child with cancer to offset expenses related to the child's cancer treatments. Funding is intended to cover costs not covered by health insurance, including travel costs, housing, and
Grants to USA nonprofit organizations to protect natural resources on land and water in locations around the world. Funding is intended to ensure that activities to acquire metals, gemstones, and corals for design use do not have an adverse impact on the area of origin.
Grants to Indiana nonprofit organizations in eligible regions for projects and capital campaigns that address community needs. Applicants requesting support for a capital campaign are asked to contact the funding source prior to submitting an application. Projects are e